Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cascadian Therapeutics Inc (NASDAQ:CASC)

4.15
Delayed Data
As of Mar 29
 +0.03 / +0.73%
Today’s Change
3.49
Today|||52-Week Range
10.98
-3.71%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
AssetsCash9.3M10.5M27.9M13.7M
 
 
 
 
 
Short Term Investment Cash-13.0M1.2M17.4M-14.1M
 
 
 
 
 
Cash & Short Term Investments60.0M57.7M56.4M62.8M
 
 
 
 
 
 
ReceivablesReceivables197.0K298.0K200.0K238.0K
 
 
 
 
 
 
InventoriesInventories----0.000.00--
 
Current AssetsOther Current Assets720.0K888.0K1.4M1.4M
 
 
 
 
 
Current Assets60.9M58.9M58.0M64.5M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross3.9M4.3M5.2M5.3M
 
 
 
 
 
Depreciation-2.2M-2.7M-3.3M-3.9M
 
 
 
 
 
Intangible Assets2.1M36.4M36.4M16.7M
 
 
 
 
 
Other Assets2.3M36.6M36.8M17.4M
 
 
 
 
 
Total Assets77.7M103.4M96.6M83.3M
 
 
 
 
 
 
LiabilitiesAccrued Expenses2.4M1.8M2.7M3.3M
 
 
 
 
 
Other Current Liabilities3.1M2.8M3.3M4.5M
 
 
 
 
 
Other Liabilities4.7M4.7M4.8M8.8M
 
 
 
 
 
 
Total LiabilitiesLong Term Debt30.0K30.0K30.0K30.0K
 
 
 
 
 
Deferred Taxes-234.0K-6.6M-6.9M0.00
 
 
 
 
Other Liabilities1.1M155.0K1.1M105.0K
 
 
 
 
 
Total Liabilities6.2M12.1M12.8M8.9M
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock0.000.000.000.00--
Common Equity71.6M91.3M83.7M74.4M
 
 
 
 
 
Total Shareholder Equity71.6M91.3M83.7M74.4M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding70.7M91.6M95.0M22.6M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.